SIGNAL TRANSDUCTION INHIBITORS AS NOVEL ANTICANCER DRUGS - WHERE ARE WE

被引：11
作者：
WORKMAN, P
机构：
[1] Cancer Research Campaign Beatson Laboratories, CRC Department of Medical Oncology, University of Glasgow, Scotland
来源：
ANNALS OF ONCOLOGY | 1992年 / 3卷 / 07期
关键词：
D O I：
10.1093/oxfordjournals.annonc.a058253
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：527 / 531
页数：5
相关论文
共 14 条
[1]  
BOYD MR, 1989, PRINCIPLES PRACTICES, V3
[2]   ONCOGENES AND SIGNAL TRANSDUCTION [J].
CANTLEY, LC ;
AUGER, KR ;
CARPENTER, C ;
DUCKWORTH, B ;
GRAZIANI, A ;
KAPELLER, R ;
SOLTOFF, S .
CELL, 1991, 64 (02) :281-302
[3]   A GENETIC MODEL FOR COLORECTAL TUMORIGENESIS [J].
FEARON, ER ;
VOGELSTEIN, B .
CELL, 1990, 61 (05) :759-767
[4]  
GRINDEY GB, 1990, CANCER CELL-MON REV, V2, P163
[5]   SCREENING METHODS IN ANTINEOPLASTIC DRUG DISCOVERY [J].
JOHNSON, RK .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (13) :1082-1083
[6]  
JOHNSON SE, 1989, J AM ANIM HOSP ASSOC, V25, P129
[7]  
POWIS G, 1990, CANCER RES, V50, P2203
[8]   SIGNALING TARGETS FOR ANTICANCER DRUG DEVELOPMENT [J].
POWIS, G .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (05) :188-194
[9]  
TRITTON TR, 1990, CANCER CELL-MON REV, V2, P95
[10]  
VENUTI MC, 1989, ANNU REP MED CHEM, V25, P289
12